Formulation: A solid
Purity: ≥98%
- PGs (egg)
- L-α-Phosphatidylglycerols (egg)
1-
A mixed chain phosphatidylglycerol
CAS No. 268550-95-4
Item No. 15105
Formulation: A crystalline solid
Purity: ≥98%
- 1-Palmitoyl-2-Oleoyl-sn-glycero-3-phosphoglycerol
- 1-Palmitoyl-2-Oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol)
- PG(16:0/18:1(9Z))
- 1,2-POPG
1,2-Dilauroyl-
A short chain phosphatidylglycerol
CAS No. 322647-27-8
Item No. 15084
Formulation: A crystalline solid
Purity: ≥95%
- 1,2-Dilauroyl-sn-glycero-3-phospho-sn-glycerol
- 1,2-DLPG
1-Palmitoyl-d9-2-Palmitoyl-sn-glycero-3-PG
An internal standard for the quantification of 1,2-dipalmitoyl-sn-glycero-3-PG
Item No. 28953
Formulation: A 1 mg/ml solution in chloroform
Purity: ≥99% deuterated forms (d1-d9)
- 1-Hexanoyl-d9-2-hexanoyl-sn-glycero-3-phosphatidylglycerol
- 1-Hexanoyl-d9-2-hexanoyl-sn-glycero-3-phosphoglycerol
- 1-Palmitoyl-d9-2-Palmitoyl-sn-glycero-3-phosphatidylglycerol
- 1-Palmitoyl-d9-2-Palmitoyl-sn-glycero-3-phosphoglycerol
- 16:0-d9/16:0-PG
- PG(16:0-d9/16:0)
Formulation: A solid
Purity: ≥95%
- 18:1 Cardiolipin
- 72:4-CL
- Diphosphatidylglycerol (18:1)
- Tetraoleoyl Cardiolipin
Formulation: A crystalline solid
Purity: ≥98%
- 1,2-Dihexadecanoyl-sn-glycero-3-phosphatidylglycerol
- 1,2-Dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol)
- 1,2-Dihexadecanoyl-sn-glycero-3-phosphoglycerol
- 1,2-
DPPG - MG 6060LS
- 16:0/16:0-PG
- PG(16:0/16:0)
Formulation: A 5 mg/ml solution in methanol
Purity: ≥95% (9:1 mixture mixture of 1', 2' acyl chain isomers))
- 1-Hexadecanoyl-2-(9(Z)12(Z)-octadecadienoyl)-sn-glycero-3-phosphoglycerol
- 1-Palmitoyl-2-linoleoyl Phosphatidylglycerol
- PG(16:0/18:2)
- PG(16:0/18:2(9Z,12Z))
- 1,2-PLPG
- PtdGly-(1-palmitoyl, 2-linoleoyl)
sPLA2 (Type V) Inhibitor Screening Assay Kit
A convenient colorimetric method of screening human sPLA2 Type V inhibitors
Item No. 702490
- GVsPLA2
- Phosphatidylcholine 2-acylhydrolase 5
- Phospholipase A2 Group V
- PLA2G5
- Secretory Phospholipase A2 (Type V)
- sPLA2-V
E. coli Total Lipid Extract
A lipid extract produced by chloroform and methanol extraction of an E. coli cell pellet
Item No. 44568
Formulation: A dried film
Formulation: A solid
Purity: ≥90%
NR5A1 (C247S, C412S mutant; human, recombinant)
Host: E. coli • AA: 218-461 • Tag: N-terminal His • MW: 31.01 kDa
Item No. 41072
Formulation: 20 mM Tris-HCl, pH 8.5, with 1 mM TCEP and 150 mM sodium chloride
- Ad4BP
- Adrenal 4-binding Protein
- Fushi Tarazu Factor Homolog 1
- Nuclear Receptor Subfamily 5 Group A Member 1
- SF-1
- Steroidogenic Factor 1
Immunogen: Recombinant human Prx6
Host: Mouse
Isotype: IgG1
Applications: ELISA, IHC-P, IP
Peroxiredoxin-6 (human, recombinant)
Host: E. coli • AA: 1-224 (full length) • Tag: N-terminal His • MW: ~25 kDa
Item No. 43211
Formulation: Lyophilized from sterile PBS, pH 7.4
Purity: ≥95% as estimated by SDS-PAGE
- aiPLA2
- Acidic Calcium-independent Phospholipase A2
- 1-Cys Peroxiredoxin
- Glutathione-dependent Peroxiredoxin
- LPCAT5
- Non-selenium Glutathione Peroxidase
- NSGPx
- PRDX6
- Prx6
Formulation: A crystalline solid
Purity: ≥95%
- 1,1,2,2-tetrakis[4-(2-Trimethylammonioethoxy)-phenylethene
Formulation: A crystalline solid
Purity: ≥90%
- CL
- Diphosphatidylglycerol
sPLA2 (human, recombinant Type IIA)
Active • Host: E. coli • AA: 1-124; variant N1A • MW: 13.9 kDa
Item No. 10206
Formulation: 50 mM Tris-HCl, pH 7.6, with 100 mM sodium chloride and 10 mM calcium chloride
Purity: ≥85% estimated by SDS-PAGE
- GIIC sPLA2
- Group IIA phospholipase A2
- Non-Pancreatic Secretory Phospholipase A2
- Phosphatidylcholine 2-Acylhydrolase 2A
- PLA2G2A
- Secretory Phospholipase A2 (Group IIA)
- sPLA2-IIA
Formulation: A 10 mg/ml solution in chloroform
Purity: ≥95%
- 16:0-18:1 Cardiolipin
- 68:2-CL
- CL(1'-[16:0/18:1],3'-[16:0/18:1])
- Diphosphatidylglycerol (16:0/18:1)
Formulation: A 5 mg/ml solution in chloroform
Purity: ≥95%
- 16:1 Cardiolipin
- 64:4-CL
- Diphosphatidylglycerol (16:1)
- Tetrapalmitoleoyl Cardiolipin
Formulation: A crystalline solid
Purity: ≥98%
Formulation: A solid
Purity: ≥98%
- 18:0 Cardiolipin
- 72:0-CL
- 4S-sn-CL
- Diphosphatidylglycerol (18:0)
- Tetrastearoyl Cardiolipin
Formulation: A solid
Purity: ≥98%
- 14:0 Cardiolipin
- 56:0-CL
- Diphosphatidylglycerol (14:0)
- Tetramyristoyl Cardiolipin
- TMCL
Formulation: A 5 mg/ml solution in chloroform
Purity: ≥95%
- 14:1 Cardiolipin
- 56:4-CL
- Diphosphatidylglycerol (14:1)
- Tetramyristoleoyl Cardiolipin
1,2-bis(heptanoylthio)-sn-glycero-3-PG (sodium salt)
A sulfur-containing phosphoglycerol
Item No. 38436
Formulation: A crystalline solid
Purity: ≥95%
- 1,2-bis(heptanoylthio) Glycerophosphatidylglycerol
- 1,2-bis(heptanoylthio) Glycerophosphoglycerol
- Diheptanoyl Thio-PG
Formulation: 25 mM Tris, pH 7.5, with 100 mM potassium chloride and 10 mM calcium chloride
Purity: ≥80% estimated by SDS-PAGE
- GIIE sPLA2
- Group IIE Secretory Phospholipase A2
- Phosphatidylcholine 2-Acylhydrolase 2E
- Phospholipase A2 Group IIE
- sPLA2-IIE
sPLA2 (Type IB) Rabbit Monoclonal Antibody (Clone 001)
For immunochemical detection of sPLA2 (Type IB)
Item No. 37088
Immunogen: Recombinant mouse sPLA2 (Type IB)
Host: Rabbit
Isotype: IgG
Applications: ELISA
Contact Info
Cayman Chemical1180 East Ellsworth RoadAnn Arbor, Michigan 48108 USAToll Free: (800) 364-9897(USA and Canada only)Fax: (734) 971-3640
